A Safety Study of SGN-CD33A in AML Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Phoenix Ho, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- City of Hope National Medical Center
Duarte, California, United States
- H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida, United States
- Winship Cancer Institute / Emory University School of Medicine
Atlanta, Georgia, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Hackensack University Medical Center
Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Cleveland Clinic, the
Cleveland, Ohio, United States
- Charles A. Sammons Cancer Center / Baylor University Medical Center
Dallas, Texas, United States
- Md Anderson Cancer Center / University of Texas
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 18 Mar 2016
- Completion
- 8 Dec 2017
- Last update posted
- 5 Jan 2018
- Registered enrollment
- 195
- Registry id
- NCT01902329
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.